Can serum HER2 testing add prognostic value to routine tissue HER2 analysis for primary breast cancer patients?

Todorović-Raković, Nataša; Milovanović, Jelena; Greenman, John; Radulović, Marko

Results

eNauka > Results > Can serum HER2 testing add prognostic value to routine tissue HER2 analysis for primary breast cancer patients?

Title:	Can serum HER2 testing add prognostic value to routine tissue HER2 analysis for primary breast cancer patients?
Authors:	Todorović-Raković, Nataša ; Milovanović, Jelena ; Greenman, John; Radulović, Marko
Issue Date:	2023
Publication:	SDIR 6. Oncology Insights. THE SIXTH CONGRESS OF THE SERBIAN ASSOCIATION FOR CANCER RESEARCH
ISSN:	3009-3848 3009-383X Oncology Insights Search Idenfier
Publisher:	Belgrade : Serbian Association for Cancer Research Beograd : Srpsko društvo istraživača raka (SDIR)
Type:	Conference Paper
Collation:	br. 1 str. 87 Abs. no, P26
VBS COBISS :	125366281
URI:	https://enauka.gov.rs/handle/123456789/849452
URL:	https://www.sdir.ac.rs/pdf/Oncology_Insights_No_1_2023.pdf
Metadata source:	(Preuzeto iz ORCID-a) Milovanović, Jelena
M-category:	Mp. category will be shown later

Find the DOI

Finding a DOI in CrossRef based on publication meta-data. The DOI (and metadata) with the similar data match will be displayed. ATTENTION - it doesn't have to be that publication.

Google Scholar^TM